Author:
Cata Juan P.,Weng Han-Rong,Dougherty Patrick M.
Reference44 articles.
1. Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients;Albertini;Clin. Cancer Res.,1997
2. Rapid deterioration in quality of life during interleukin-2- and alpha-interferon-based home therapy of renal cell carcinoma is associated with a good outcome;Atzpodien;Br. J. Cancer,2003
3. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R{beta} receptor;Azimi;J. Immunol.,1999
4. Changes in hippocampal IL-15, related cytokines, and neurogenesis in IL-2 deficient mice;Beck;Brain Res.,2005
5. Interleukin 2 modifies the bioelectric activity of some neurosecretory nuclei in the rat hypothalamus;Bindoni;Brain Res.,1988
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献